AstraZeneca Market Cap 2006-2019 | AZN

AstraZeneca market cap history and chart from 2006 to 2019. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of diluted shares outstanding. AstraZeneca market cap as of May 21, 2019 is $95.08B.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $95.085B $22.090B
AstraZeneca PLC is one of the top five pharmaceutical companies in the world based on sales and is a therapeutic leader in cardiovascular, gastrointestinal, oncology, anesthesia including pain management, central nervous system (CNS) and respiratory products. They are engaged in the research, development, manufacture and marketing of ethical (prescription) pharmaceuticals and agricultural products, and the supply of healthcare services.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $371.367B 16.84
Pfizer (PFE) United States $247.580B 13.50
Merck (MRK) United States $212.675B 17.49
Novartis AG (NVS) Switzerland $189.443B 16.37
AbbVie (ABBV) United States $118.000B 9.76
Novo Nordisk (NVO) Denmark $115.481B 19.21
Eli Lilly (LLY) United States $112.840B 20.94
Sanofi (SNY) France $103.910B 12.75
GlaxoSmithKline (GSK) United Kingdom $97.711B 12.39
Bristol-Myers Squibb (BMY) United States $75.750B 11.19